Evidence map›Paper›PMID 34445713›Full record

SynthesisInternational journal of molecular sciences2021

Tissue-Resident Memory T Cells in Skin Diseases: A Systematic Review.

Thomas Emmanuel, Josephine Mistegård, Anne Bregnhøj, Claus Johansen, Lars Iversen

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. When Checkpoint Inhibitors Break Barriers: Mechanisms and Challenges of irAEs of the Skin, Gastrointestinal Tract, and Lung.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Tumor-embedded Immunity and TRM Cell Functions in Cancer.Mini reviews in medicinal chemistry · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Tissue-Resident Memory T Cells in Allergy.Clinical reviews in allergy & immunology · 2024
    Review
  14. From PsO to PsA: the role of TFrontiers in medicine · 2024
    Review
  15. Review
  16. Exploring Mast Cell-CD8 T Cell Interactions in Inflammatory Skin Diseases.International journal of molecular sciences · 2023
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Thomas EmmanuelDepartment of Dermatology, Aarhus University Hospital, DK-8200 Aarhus, Denmark.ORCID 0000-0003-3161-6409
Josephine MistegårdDepartment of Dermatology, Aarhus University Hospital, DK-8200 Aarhus, Denmark.
Anne BregnhøjDepartment of Dermatology, Aarhus University Hospital, DK-8200 Aarhus, Denmark.
Claus JohansenDepartment of Dermatology, Aarhus University Hospital, DK-8200 Aarhus, Denmark.
Lars IversenDepartment of Dermatology, Aarhus University Hospital, DK-8200 Aarhus, Denmark.
Aarhus University Hospital · DK

Funding

Aarhus University Not specifiedDanish Psoriasis Association Not specifiedFonden til Lægevidenskabens Fremme 19-L-0131Knud Højgaards Fond 20-02-0198Kongelig Hofbuntmager Aage Bangs Fond Not specified
6 · The paper itself

Abstract

In health, the non-recirculating nature and long-term persistence of tissue-resident memory T cells (TRMs) in tissues protects against invading pathogens. In disease, pathogenic TRMs contribute to the recurring traits of many skin diseases. We aimed to conduct a systematic literature review on the current understanding of the role of TRMs in skin diseases and identify gaps as well as future research paths. EMBASE, PubMed, SCOPUS, Web of Science, Clinicaltrials.gov and WHO Trials Registry were searched systematically for relevant studies from their inception to October 2020. Included studies were reviewed independently by two authors. This study was conducted in accordance with the PRISMA-S guidelines. This protocol was registered with the PROSPERO database (ref: CRD42020206416). We identified 96 studies meeting the inclusion criteria. TRMs have mostly been investigated in murine skin and in relation to infectious skin diseases. Pathogenic TRMs have been characterized in various skin diseases including psoriasis, vitiligo and cutaneous T-cell lymphoma. Studies are needed to discover biomarkers that may delineate TRMs poised for pathogenic activity in skin diseases and establish to which extent TRMs are contingent on the local skin microenvironment. Additionally, future studies may investigate the effects of current treatments on the persistence of pathogenic TRMs in human skin.

Indexed as

CD8-Positive T-LymphocytesHumansImmunologic MemoryLymphoma, T-Cell, CutaneousOrgan SpecificityPsoriasisSkinSkin DiseasesT-LymphocytesVitiligoinflammationskin diseasesystematic reviewT cellstissue-resident memory T cellsTRMTRMs

Identifiers

PMID34445713
PMCPMC8396505
OpenAlexW3194712095

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.